To the editor： Dual antiplatelet therapy （DAPT） is mandatory for the prevention of thrombosis at least for one year after especially drug-eluting stent implantation as recommended by the guidelines. In patients re...To the editor： Dual antiplatelet therapy （DAPT） is mandatory for the prevention of thrombosis at least for one year after especially drug-eluting stent implantation as recommended by the guidelines. In patients receiving anticoagulants, optimal antiplatelet regimen is still a debatable issue because of its higher bleeding risk. The guidelines strongly recommend us to assess the riskbenefit ratio, t展开更多
To the editor： Cardiogenic shock is one of the devastating complications of acute myocardial infarction. The mortalityrate is still unacceptably high though having some treatment options such as complete revasculariz...To the editor： Cardiogenic shock is one of the devastating complications of acute myocardial infarction. The mortalityrate is still unacceptably high though having some treatment options such as complete revascularization, vasoactive drugs and mechanical support devices. Intra-aortic balloon pump （IABP） is the oldest and most frequently used supporting method. In one of the past issues of the journal, Wu et alJ retrospectively analyzed the factors affecting the outcomes of the elderly Chinese patients with cardiogenic shock treated with IABP. This study stimulated us to bring up some controversial issues of IABP support. Some current data in terms of IABP usage should be reviewed more comprehensively beyond knowing the factors affecting the outcomes.展开更多
To the editor： We read with great interest a longitudinal study by Zhang et al.1 The authors reported that transradial approach（TRA） reduced bleeding complication, and improved 30-day clinical outcomes. Despite a n...To the editor： We read with great interest a longitudinal study by Zhang et al.1 The authors reported that transradial approach（TRA） reduced bleeding complication, and improved 30-day clinical outcomes. Despite a non-randomized study, it would provide an important contribution regarding TRA in patients with ST-segment elevation myocardial infarction （STEMI） treated with contemporary antitrombotic therapy such as tirofiban, which still remains unclear.展开更多
To the editor： In a recently published issue, we have greatly enjoyed reading a well-designed study entitled ＂Three hourscontinuous injection ot aOenoslne lmprovea tert ventrlcumr function and infarct size in patien...To the editor： In a recently published issue, we have greatly enjoyed reading a well-designed study entitled ＂Three hourscontinuous injection ot aOenoslne lmprovea tert ventrlcumr function and infarct size in patients with ST-segment elevation myocardial infarction＂. Zhang et al investigated the effect of 3 hours infusion of adenosine started just after passing of a coronary guidewire during primary percutaneous intervention on left ventricular function and infart size in patients with ST-segment elevation myocardial infarction （STEMI）. They reported favorable results with adenosine infusion and, discussed some possible mechanisms and large studies in their article.1 For better understanding of adenosine-mediated cardioprotection, some additional information appears to be needed.展开更多
文摘To the editor： Dual antiplatelet therapy （DAPT） is mandatory for the prevention of thrombosis at least for one year after especially drug-eluting stent implantation as recommended by the guidelines. In patients receiving anticoagulants, optimal antiplatelet regimen is still a debatable issue because of its higher bleeding risk. The guidelines strongly recommend us to assess the riskbenefit ratio, t
文摘To the editor： Cardiogenic shock is one of the devastating complications of acute myocardial infarction. The mortalityrate is still unacceptably high though having some treatment options such as complete revascularization, vasoactive drugs and mechanical support devices. Intra-aortic balloon pump （IABP） is the oldest and most frequently used supporting method. In one of the past issues of the journal, Wu et alJ retrospectively analyzed the factors affecting the outcomes of the elderly Chinese patients with cardiogenic shock treated with IABP. This study stimulated us to bring up some controversial issues of IABP support. Some current data in terms of IABP usage should be reviewed more comprehensively beyond knowing the factors affecting the outcomes.
文摘To the editor： We read with great interest a longitudinal study by Zhang et al.1 The authors reported that transradial approach（TRA） reduced bleeding complication, and improved 30-day clinical outcomes. Despite a non-randomized study, it would provide an important contribution regarding TRA in patients with ST-segment elevation myocardial infarction （STEMI） treated with contemporary antitrombotic therapy such as tirofiban, which still remains unclear.
文摘To the editor： In a recently published issue, we have greatly enjoyed reading a well-designed study entitled ＂Three hourscontinuous injection ot aOenoslne lmprovea tert ventrlcumr function and infarct size in patients with ST-segment elevation myocardial infarction＂. Zhang et al investigated the effect of 3 hours infusion of adenosine started just after passing of a coronary guidewire during primary percutaneous intervention on left ventricular function and infart size in patients with ST-segment elevation myocardial infarction （STEMI）. They reported favorable results with adenosine infusion and, discussed some possible mechanisms and large studies in their article.1 For better understanding of adenosine-mediated cardioprotection, some additional information appears to be needed.
